| Literature DB >> 31921715 |
Sarah A Ingelse1, Vincent G Geukers1, Monique E Dijsselhof2, Joris Lemson3, Reinout A Bem1, Job B van Woensel1.
Abstract
Background: Fluid overload is common in critically ill children and is associated with adverse outcome. Therefore, restricting fluid intake may be beneficial. This study aims to study the feasibility of a randomized controlled trial (RCT) comparing a conservative to a standard, more liberal, strategy of fluid management in mechanically ventilated pediatric patients with acute respiratory tract infection (ARTI).Entities:
Keywords: bronchiolitis; child health; critical care; feasibility studies; fluid therapy; respiratory tract infection
Year: 2019 PMID: 31921715 PMCID: PMC6915071 DOI: 10.3389/fped.2019.00496
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Figure 1Enrolment and randomization. Patients were screened if at least one of the inclusion criteria (respiratory insufficiency due to possible viral infection) was met. This figure shows reasons for exclusion and subsequent enrolment for patients who consented to participation.
Baseline demographic and clinical characteristics of mechanically ventilated patients with acute respiratory tract infection.
| Age (months), median [25–75th percentiles] | 2.7 [0.8–10.1] | 3.4 [0.8–11.5] | 2.7 [0.8–6.7] |
| Sex, male, | 13 (57) | 6 (50) | 7 (64) |
| Admission weight in kg, median [25–75th percentiles] | 5.5 [3.9–8.2] | 5.7 [4.3–9.8] | 5.5 [3.4–8.2] |
| History of chronic illness | 4 (17) | 4 (33) | 0 (0) |
| RSV positive, | 17 (74) | 11 (92) | 6 (55) |
| Bacterial (super)infection | 9 (39) | 6 (50) | 3 (27) |
| Pediatric Index of Mortality 2 score, median [25–75th percentiles] | 1.3 [1.1–2.1] | 1.3 [1.0–2.2] | 1.5 [1.1–2.1] |
| Oxygen saturation index at day of admission, median [25–75th percentiles] | 6.1 [4.0–7.4] | 6.6 [3.9–8.1] | 6.1 [4.1–6.5] |
Chronic illness included prematurity with bronchopulmonary dysplasia, muscle-eye-brain disease, and epilepsy.
Positive cultures of tracheal aspirate or bronchial lavage fluid included one or more of the following bacteria: Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Staphylococcus aureus.
Feasibility and safety parameters per fluid strategy.
| Adherence to fluid intake, % of study days; median [25–75th percentiles] | 75.0 [50.0–96.4] | 66.7 [40.0–100.0] | 0.474 | −19 to 35; median difference: 4.5 |
| Calorie intake, kcal/kg; median [25–75th percentiles] | 67.9 [51.5-74.0] | 67.2 [58.0-75.2] | 0.878 | −17.3 to 10.7; median difference: −0.7 |
| Protein intake, gr protein/kg; median [25–75th percentiles] | 1.6 [1.3–1.8] | 1.5 [1.2–1.7] | 0.598 | −0.2 to 0.4; median difference: 0.1 |
| Cumulative fluid intake day 3, ml/kg; mean ± SD | 262.2 (±58.9) | 360.5 (±52.6) | <0.001 | −146.8 to −49.7; effect size: 1.8 |
| Cumulative furosemide day 3, mg/kg; median [25−75th percentiles] | 0.9 [0.08–2.2] | 0.5 [0.0–1.0] | 0.361 | −0.5 to 1.5; median difference: 0.3 |
| Cumulative diuresis at day 3, in ml/kg; mean ±SD | 174.1 (±55.5) | 265.0 (±36.6) | <0.001 | −132.1 to −49.8; effect size: 1.9 |
| Patients who received fluid boluses, N (%) | 3 (25) | 3 (26) | 0.901 | OR 0.89; 0.14–5.73 |
| Acute Kidney Injury (AKI), grade I, | 4 (33) | 0 (0) | 0.093 | n.a. |
| Difference mean BP day 3–day 1, in mmHg, mean ±SD | −6.2 (±10.9) | 1.9 (±10.4) | 0.098 | −1.6 to 17.9; effect size: 0.8 |
| Difference heart rate day 3–day 1, in beats/min, mean ±SD | −13.0 (±22.2) | 3.2 (±19.9) | 0.081 | −2.2 to −34.5; effect size: 0.8 |
No significant differences in the feasibility and safety parameters occurred between the two groups. Diuresis was significantly higher in the standard group. Parametric data was analyzed using an independent-samples t-test. Non-parametric data was analyzed using a Mann-Whitney U test. Proportions were analyzed using logistic regression, or if count was zero: Fisher's exact test.
Figure 2Fluid intake per fluid strategy in percentage of normal fluid recommendation. Normal fluid recommendations are based on Shaw (19). Patients in the standard fluid strategy were allocated to stay above 85% of this fluid volume. Patients in the conservative fluid strategy were deemed to stay below 70% of this recommendation. Plot depicts median with 25 and 75th percentiles and the whiskers represent minimum and maximum, over all patients in each group. This shows the large spread per day between patients.
Figure 3Blood pressure and heart rate over time. Blood pressure and heart rate for both groups portrayed over time. Blood pressure is found on the left Y-axis, heart rate on the right Y-axis. Plot depicts mean with the whiskers representing liberal error of the mean, over all patients in each group. There was no significant difference between groups over time for both parameters as tested by linear-mixed model (p = 0.687 for BP, p = 0.387 for HR).
Electrolyte imbalances.
| Hyponatremia, | 5 (42) | 3 (27) | 0.667 |
| Hypernatremia, | 1 (8) | 0 (0) | 1.000 |
| Hypokalemia, | 2 (17) | 0 (0) | 0.478 |
| Hyperkalemia, | 3 (25) | 4 (36) | 0.667 |
| Hypochloremia, | 4 (33) | 1 (9) | 0.317 |
| Hyperchloremia, | 0 (0) | 0 (0) | - |
No significant differences in the occurrence of imbalances were found between the two groups. Electrolytes were deemed out of balance when values were out of the normal range for more than one day consecutively. Normal ranges used were: sodium 135–145 mmol/L; potassium 3.5–5.2 mmol/L; chloride 96–111 mmol/L. Differences in occurrence of electrolyte imbalances were tested using the Fisher's exact test.
Figure 4Cumulative Fluid intake and Urine output on Day 3. Fluid intake and urine output were significantly different between the conservative and standard fluid arm (p < 0.001). This did however not result in a difference in fluid balance as can be deducted from this figure. Bar graphs depict mean and SD. Differences between groups were tested using independent-samples t-tests. ** p<0.001.